Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
Clinical trial NCT00078572 · COMPLETED
Trial details
- NCT number
- NCT00078572
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-04-01
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.